A double-blind, placebo-controlled, randomized, dose-escalating study of single (Part A) and muliple (Part B) intravenous doses of friulimicin B in healthy subjects

Trial Profile

A double-blind, placebo-controlled, randomized, dose-escalating study of single (Part A) and muliple (Part B) intravenous doses of friulimicin B in healthy subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2008

At a glance

  • Drugs Friulimicin B (Primary)
  • Indications Bacterial infections; Nosocomial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 22 Jul 2008 Status changed from recruiting to discontinued (based on information from ClinicalTrials.gov). This trial was terminated as a result of unfavourable pharmacokinetics.
    • 10 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top